Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Genmab A/S (GB:0MGB)
LSE:0MGB
Holding GB:0MGB?
Track your performance easily
See the Price Targets and Ratings of:
0MGB Analyst Ratings
Moderate Buy
5 Buy
2 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
0MGB Stock 12 Month Forecast
Average Price Target
kr2,500.00
▲(41.64% Upside)
| Highest Price Targetkr2,850 | Average Price Targetkr2,500 | Lowest Price Targetkr2,050 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Bank of America Securities
Reiterated
09/19/24
Deutsche Bank
Reiterated
08/30/24
J.P. Morgan
Downgraded
08/20/24
Barclays
Reiterated
08/14/24
RBC Capital
Upgraded
07/15/24
Guggenheim
Reiterated
06/27/24
Citi
Reiterated
06/04/24
TD Cowen
Reiterated
04/03/24
Jefferies
Reiterated
02/26/24
DNB Markets
kr2,450
Buy
38.81%
Upside
Upgraded
11/08/23
Genmab upgraded to Buy from Sell at DNB MarketsGenmab upgraded to Buy from Sell at DNB Markets
Goldman Sachs
kr2,736→kr2,808
Hold
59.09%
Upside
Reiterated
09/28/23
Genmab A/S (GEN:DC) (GMAB) PT Raised to DKK2,808 at Goldman SachsGoldman Sachs analyst Rajan Sharma raised the price target on Genmab A/S (GEN:DC) (NASDAQ: GMAB) to DKK2,808.00 (from DKK2,736.00) while maintaining a Neutral rating.
Unknown Analyst
Not Ranked
Exane BNP Paribas
kr2,000
Sell
13.31%
Upside
Initiated
10/18/23
Genmab initiated with an Underperform at Exane BNP ParibasGenmab initiated with an Underperform at Exane BNP Paribas
Best Analysts Covering Genmab A/S
Which Analyst Should I Follow If I Want to Buy GB:0MGB and Sell After:
1 Month
xxx
Success Rate
9/13 ratings generated profit
Average Return
+1.85%
reiterated a xxx
rating 22 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 69.23% of your transactions generating a profit, with an average return of +1.85% per trade.
3 Months
xxx
Success Rate
21/33 ratings generated profit
Average Return
+3.29%
reiterated a xxx
rating last month
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 63.64% of your transactions generating a profit, with an average return of +3.29% per trade.
1 Year
Success Rate
18/33 ratings generated profit
Average Return
+15.57%
reiterated a buy rating last month
Copying Emily Field's trades and holding each position for 1 Year would result in 54.55% of your transactions generating a profit, with an average return of +15.57% per trade.
2 Years
xxx
Success Rate
9/13 ratings generated profit
Average Return
+11.88%
reiterated a xxx
rating 22 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 69.23% of your transactions generating a profit, with an average return of +11.88% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
0MGB Analyst Recommendation Trends
Rating
May 24
Jun 24
Jul 24
Aug 24
Sep 24
Strong Buy
0
1
2
4
6
Buy
8
9
9
8
5
Hold
2
3
2
2
1
Sell
2
2
2
1
0
Strong Sell
0
0
0
0
0
total
12
15
15
15
12
Each month's total comprises the sum of three months' worth of ratings.
0MGB Financial Forecast
0MGB Stock Forecast FAQ
What is GB:0MGB’s average 12-month price target, according to analysts?
Based on analyst ratings, Genmab A/S’s 12-month average price target is kr2,500.00.
What is GB:0MGB’s upside potential, based on the analysts’ average price target?
Genmab A/S has 41.64% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Genmab A/S a Buy, Sell or Hold?
Genmab A/S has a consensus rating of Moderate Buy, which is based on 5 buy ratings, 2 hold ratings and 0 sell ratings.
What is Genmab A/S’s share price target?
The average share price target for Genmab A/S is kr2,500.00. This is based on 7 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is kr2,850.00 ,and the lowest forecast is kr2,050.00. The average share price target represents 41.64% Increase from the current price of kr1,765.
The highest analyst share price target is kr2,850.00 ,and the lowest forecast is kr2,050.00. The average share price target represents 41.64% Increase from the current price of kr1,765.
What do analysts say about Genmab A/S?
Genmab A/S’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 7 Wall Streets Analysts.
How can I buy shares of Genmab A/S?
To buy shares of GB:0MGB, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.